Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Май 4, 2021
Bacterial
therapeutics
are
the
emergent
alternatives
in
treating
autoimmune
diseases
such
as
Rheumatoid
Arthritis
[RA].
P.
histicola
MCI
001
is
one
therapeutic
bacterium
that
has
been
proven
to
treat
RA
and
multiple
sclerosis
[MS]
animal
models.
The
present
study
characterized
isolated
from
a
human
duodenal
biopsy,
evaluated
its
impact
on
gut
microbial
metabolic
profile
longitudinal
using
collagen-induced
arthritis
model
HLA-DQ8.AEo
transgenic
mice.
though
closely
related
type
strain
of
,
DSM
19854,
differed
utilizing
glycerol.
In
culture,
produced
vitamins
biotin
folate,
was
involved
digesting
complex
carbohydrates
production
acetate.
Colonization
showed
duodenum
predominant
niche
for
gavaged
001.
A
follow-up
arthritic
mice
treated
with
suggested
dysbiosis
caused
due
partially
restored
naïve
after
treatment.
taxon-level
analysis
an
expansion
intestinal
genus
Allobaculum
MCI001
Eubiosis
achieved
post
treatment
also
reflected
increased
short-chain
fatty
acids
[SCFAs].
Present
suggests
leads
by
increasing
availability
simple
Restoration
metabolites
like
butyrate
induce
immune
homeostasis.
Frontiers in Immunology,
Год журнала:
2020,
Номер
11
Опубликована: Апрель 9, 2020
Gut
dysbiosis,
namely
dysregulation
of
the
intestinal
microbiota,
and
increased
gut
permeability
lead
to
enhanced
inflammation
are
commonly
seen
in
chronic
conditions
such
as
obesity
aging.
In
people
living
with
HIV
(PLWH),
several
lines
evidence
suggest
that
a
depletion
CD4
T-cells
is
associated
microbial
translocation
systemic
inflammation.
Antiretroviral
therapy
(ART)
rapidly
controls
viral
replication,
which
leads
T-cell
recovery
control
disease.
However,
epithelial
damage
persist
despite
ART,
increasing
risk
developing
inflammatory
non-AIDS
comorbidities
cardiovascular
disease,
diabetes
mellitus,
liver
steatosis
cancer.
addition
an
emerging
research
priority
discover
strategies
improve
composition
barrier
function.
Probiotic
interventions
have
been
extensively
used
controversial
benefits
humans.
Encouragingly,
within
last
decade,
symbiotic
bacterium
Akkermansia
muciniphila
has
emerged
"sentinel
gut."
A
lower
abundance
A.
shown
diabetic
obese
well
PLWH.
Interventions
high
levels
polyphenols
tea
or
diets
rich
fruit,
antibiotic
vancomycin
antidiabetic
drug
metformin
increase
abundance,
contributing
improved
metabolic
function
individuals.
We
hypothesize
microbiota
can
reduce
inflammation,
preventing
occurrences
To
this
aim,
we
will
discuss
protective
effect
its
potential
applications,
paving
way
toward
novel
therapeutic
health
Journal of the American Heart Association,
Год журнала:
2019,
Номер
8(17)
Опубликована: Авг. 27, 2019
Background
Metabolic
syndrome
(MetS)
is
a
serious
health
problem
over
the
world;
thus,
aim
of
present
work
was
to
develop
lifestyle
intervention
decrease
dysbiosis
gut
microbiota
and
reduce
biochemical
abnormalities
MetS.
Methods
Results
The
prevalence
MetS
evaluated
in
1065
subjects
Mexico
City,
Mexico,
subsample.
Subjects
with
were
selected
for
pragmatic
study
based
on
low‐saturated‐fat
diet,
reduced‐energy
intake,
functional
foods
physical
activity,
second
group
randomized
control‐placebo
assess
after
dietary
intervention.
Prevalence
53%,
higher
body
mass
index,
dysbiosis.
Homeostatic
Model
Assessment
Insulin
Resistance,
lower
high‐density
lipoprotein
cholesterol
concentration.
revealed
that
15
days
there
24%
reduction
serum
triglycerides;
75‐day
intervention,
reduced
by
44.8%,
low‐density
cholesterol,
small
particles,
glucose
intolerance,
lipopolysaccharide,
branched‐chain
amino
acid.
showed
associated
Prevotella/
Bacteroides
ratio
an
increase
abundance
Akkermansia
muciniphila
Faecalibacterium
prausnitzii
.
Conclusions
A
significantly
decreased
components,
particle
concentration,
dysbiosis,
metabolic
endotoxemia,
reducing
risk
atherosclerosis.
Clinical
Trial
Registration
URL:
https://www.clinicaltrials.gov
Unique
identifier:
NCT03611140.
Journal of Medical Microbiology,
Год журнала:
2021,
Номер
70(10)
Опубликована: Окт. 8, 2021
Alteration
in
the
composition
of
gut
microbiota
can
lead
to
a
number
chronic
clinical
diseases.
Akkermansia
muciniphila
is
an
anaerobic
bacteria
constituting
3–5%
microbial
community
healthy
adults.
This
bacterium
responsible
for
degenerating
mucin
gut;
its
scarcity
leads
diverse
disorders.
In
this
review,
we
focus
on
role
A.
diabetes,
obesity
and
atherosclerosis,
as
well
use
next-generation
probiotic.
regard
human
animal
trials
have
shown
that
controls
essential
regulatory
system
glucose
energy
metabolism.
However,
underlying
mechanisms
by
which
alleviates
complications
obesity,
diabetes
atherosclerosis
are
unclear.
At
same
time,
abundance
suggests
improved
metabolic
disorders,
such
endotoxemia,
adiposity
insulin
resistance
tolerance.
The
implicated
declining
aortic
lesions
atherosclerosis.
Well-characterized
virulence
factors,
antigens
cell
wall
extracts
may
act
effector
molecules
these
These
provide
novel
strategies
could
be
used
probiotic
treatment
Nutrients,
Год журнала:
2018,
Номер
10(11), С. 1613 - 1613
Опубликована: Ноя. 1, 2018
In
recent
years,
attention
has
been
given
to
the
role
potentially
played
by
gut
microbiota
in
development
of
obesity.
Several
studies
have
shown
that
individuals
with
obesity,
composition
can
be
significantly
different
from
lean
individuals,
faecal
bacteria
exert
a
fundamental
modulating
energy
metabolism,
and
modifications
associated
increases
or
reductions
body
weight
mass
index.
Based
on
this
evidence,
manipulation
probiotics
considered
possible
method
prevent
treat
However,
despite
great
amount
data,
use
obesity
related
problems
remains
debated.
Studies
found
probiotic
effect
metabolism
is
strain
specific
only
some
species
included
Lactobacillus
Bifidobacterium
genera
are
effective,
whereas
other
strains
deleterious.
dosage,
duration
administration,
long-term
effects
administration
overweight
not
known.
Further
needed
before
rationally
prescribed
for
prevention
treatment
Control
diet
environmental
life-style
factors
favour
remain
best
solution
gain.
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Май 4, 2021
Bacterial
therapeutics
are
the
emergent
alternatives
in
treating
autoimmune
diseases
such
as
Rheumatoid
Arthritis
[RA].
P.
histicola
MCI
001
is
one
therapeutic
bacterium
that
has
been
proven
to
treat
RA
and
multiple
sclerosis
[MS]
animal
models.
The
present
study
characterized
isolated
from
a
human
duodenal
biopsy,
evaluated
its
impact
on
gut
microbial
metabolic
profile
longitudinal
using
collagen-induced
arthritis
model
HLA-DQ8.AEo
transgenic
mice.
though
closely
related
type
strain
of
,
DSM
19854,
differed
utilizing
glycerol.
In
culture,
produced
vitamins
biotin
folate,
was
involved
digesting
complex
carbohydrates
production
acetate.
Colonization
showed
duodenum
predominant
niche
for
gavaged
001.
A
follow-up
arthritic
mice
treated
with
suggested
dysbiosis
caused
due
partially
restored
naïve
after
treatment.
taxon-level
analysis
an
expansion
intestinal
genus
Allobaculum
MCI001
Eubiosis
achieved
post
treatment
also
reflected
increased
short-chain
fatty
acids
[SCFAs].
Present
suggests
leads
by
increasing
availability
simple
Restoration
metabolites
like
butyrate
induce
immune
homeostasis.